Further experiments revealed that miR-147a upregulation promoted TNF-α/IFN-γ-treated keratinocyte proliferation and repressed inflammatory injury, suggesting that miR-147a upregulation might be a potential therapeutic strategy for AD. Here, IFNG is linked to Alzheimer disease.